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T lymphocytes adhere to dermal microvascular en-
dothelial cells (DMEC) as the first step ill. their emi-
gration from the blood vasculature into diseased 
skin. Earlier studies have shown that the adhesiveness 
of cultured DMEC from normal skin for lymphocytes 
can be blocked by transforming growth factor-Ill 
(TGF-{ll). In contrast, TGF-{ll has no effect on the 
adhesive properties ofDMEC from psoriatic plaques, 
and this response is attenuated by the addition of 
interleukin-4 (IL-4). In the present study, we show 
that both TGF-{ll and TGF-{l2, and to a lesser extent 
TGF-{l3 isoforms block the ability of normal but not 
psoriatic DMEC to bind lymphocytes. Pretreatment 
with TGF-{ll selectively inhibited the tumor necrosis 
factor-a (TNF-a)-stimulated expression ofE-selectin 
on normal DMEC but had no effect on psoriatic 
DMEC. Scatchard analysis revealed both low- and 
T· lymphocytes adhere to dermal micro vasculal' endo-thelial cell s (DMEC) as the initial step for entry into diseased skin [1-3]. R ecen t studies have provided strong evidence that cytokines differential1 y reguiate the adhesive prope rties ofDMEC [4- 6]. Pro.inAam-
matory cytokines such as interl eukin-1 (IL-l), tumo r necrosis 
facto r-a (TNF-a ) , imerferon-,), (I FN- ')') , and IL-4 stimulate the 
adhesiveness of DMEC isolated from n orm al skin o r psoria tic 
plaques for T cells . and monocytes. Conversely, transforming 
growth fuctor-{31 (TGF-{31) inhibits the abili ty of normal DMEC to 
bind leukocytes and m o nonuclear cells [7]. TGF-{31 also blocks the 
increased adhesiveness stimulated by T NF-a or IFN-,)" bu t has littl e 
effect on IL-4-induced stimulation of DMEC adhesiveness. T hese 
observations suggest a dynamic ro le for cytokines in contro llin g 
lymphocyte traffic. R ecently, w e reported that, contrary to what 
happens in normal skin, TGF- {31 has no effect on lymphocyte 
adhesion to unstimulated or TNF-a-stimulated DMEC £i'om pso-
ria.tic plaques [8] . At present, it is unclear whether the loss of 
response of pSQl;atic DMEC to TGF-{31 is a result of alteration in 
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high-affinity receptors on normal DMEC. The base-
line number of high-affinity TGF-{l receptors was 
significantly reduced on psoriatic DMEC, whereas 
IL-4 treatment of DMEC altered the binding affinity 
but not the number of receptors. The protein and 
mRNA transcripts of type I and type II TGF-{l recep-
tor genes were detectable in psoriatic DMEC. A 
reduction in the autophosphorylation of the TGF-{l 
type II receptor protein, a constitutively active 
serine/threonine kinase, however, was detected in 
psoriatic DMEC. These i." vitrro findings suggest that 
reduction ofTGF-{l receptor expression and function 
may contribute to lymphocyte infiltration into psori-
atic plaques ill villo by allowing dermal nlicrovascular 
endothelium to escape from the negative regulation 
by TGF-{l. ] lIwes( D Cl'lllatoi 106:225-231, 1996 
membran e recepto rs fo r TGF-{31 o r defects in post-receptor signal 
transduction pathway. 
T hree distinct TGF-{3 isoforms, denoted TGF-{31, TGF-{32, and 
TGF-{33, have been identified and exhibit similar, but not identica l, 
biological activities ;/1 p;fro (reviewed in [9]). Sign al transd uctio n for 
these isofonns is mediated through a heterodil11e l~i c transmembrane 
compl ex comprised of the type I and type II receptor [10-15] . 
Studies on TGF-(3-induced phosphorylation of the receptor mol e-
cules have shown that TGF-{3 first binds to the type II recepto r. a 
consti cu tively active serinelthreonine kinase. T he type I receptor is 
then recruited in to the comp lex and is phosphorylated by the type 
Il receptor kinase activ ity, leading to activa tion of yet uniden tified 
downstream components in the signal tran sdu ction pathway 115]. 
T umor cells that have acqui red res ist,lI1ce to the growth inhibitory 
effect of TGF-{3 often show alteration of TGF-{3 receptors type I 
and II expression [1 6 -1 8] . In additio n , some epithelial cell mutants 
also exhibit point mutations in the extracellular and transm embrane 
domain of the TGF-{3 type) receptor and arc res istant to TGF-{3 
growth inhibition ('J 9]. 
In thi s report, we have amplifi ed o ur earli er observation of 
TGF-$l unrespo nsiveness by psoriatic endothe lium by m easuring 
the e ffects ofTGF- {3 isoforms on DMEC adhesiveness for lympho-
cytes as well as endotheljal cell adh esion molecules expression. We 
show that the number of high-aftini ty TGF-{3 receptors and TGF-{3 
type [I receptor autophosphorylatio n are red uced in pson aoc 
D MEC. T hese results provide furthe r evidence tha t psoriatic 
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DMEC m ay escap e the n o rmal inhibitory e ffec ts ofTGF-{3 isofonn s 
on e ndothelial cell adhesivene ss for lymph ocytes. 
MATER.l ALS AN D METH O DS 
P a tients Skin samples w ere o bt;1incd fro 11"1 Seven p;l tic l1ts wi th chro nic , 
large plaque- type psoriasis that had not been treated either topicall y o r 
systemically ft" a period o f at least 4 wk and who had undergone clinica l 
progression o f tl",ir disease. After info rmed consent was obtained, 4-l11m 
punch bio psies we re taken 6 '0111 the center o f psoriati c plaques . Fo r normal 
skill , 4-mm punch biopsies were obtained from th l! back of fi ve volunteers. 
All protoco ls fo r human subjects were preapprovcd by the Institutional 
R eview Boa rds of the Unjver.~ ity of Miami and the Mi;lI11i VA Medical 
Center. 
Endothelial Cell Preparation DerI1l al microvascular endothelial ce lls 
(DMEC) were iso lated from normal and psoriati c skin and propagated as 
described in detail elsewhere l7 ,8]. The primary DMEC cultures were 
routinely used at the second and third passages. Flow cyrometry analysis 
indica ted that > 95% of the cul tured cell s stained fo r fa cto r VlIl-related 
antigen. T he ce lls also incorporated diacctylated low density lipoprotein and 
stained pos iti ve with Ulex europeus lectin. DM EC at confluence were 
removed Ii'om thc culture dishes by trcatment with trypsin- e th ylcncdia-
1l1inc tc tr<tn cc~i.t acid, vlashed once in culture nl cdiul11, and resuspended at 
'\ X 10' cclls/ml. Aliquo ts (0.5 1ll1) were then cultured for 16 h in 
gela tin-coated 24-well culture pla tes fo r experimental assays. 
Monoliuclear CeU-DMEC Binding Assays Normal and psoria tIc 
D MEC were subcultured in to 48-well plates and reached coniluence 
overnjght. T he DM EC mono la yer was incubated with difre ren t concentra-
ti ons of TGF-,B for different period of time and washed twic" befo re the 
adherence assay. Pc.ripheral blood mononuclear cells (PBM C) were isolated 
from buffy coa ts o btained fro m normal bl ood dono rs at the Ameri can R.ed 
C ross o f South I' lorida. PBM C were resuspended at 'l X 10" cells/ml in 
Dulbccco's modified Eagle 's medium containing S'Y. fe t,,1 bovine serum . 20 
mM N-2-hydroxyethylpiperaz in e-N ' -2-e thanesul fo ni c acid (H EPES) , and 
'100 p,Ci 5IC rO " (New EI1~I ; ll1d Nuclear, Haston. MA) fo r I h at 37°C. After 
was hing fo ur times with phosph" te-bufrered saline (PBS) containing O.5'X, 
bovine serum albumin. PBMC were resuspended at 1 X 107 / ml in assay 
medium and 0 .25 ml of ce ll suspens ion was added to each well o f the 
DM EC mono la ye r. Afte r incubation at 37°C , 5%, CO2 fo r 1 h. the 
ne nadhcrent PBM C were washed off fo ur ti mes with assay medium . The 
adherent I'13M C were tht:n lysed by adding 0 .5 1111 o f 1 % Triton X-J 00 to 
each well and SICr rad ioacti vity recovered and co un ted . Ft.esults were 
expressed as percent o f bound radioacti vity/ to tal radioactivi ty added . 
Flow Cytollletry Analysis of Cell Surface Adhesion Molecular 
Expression N ormal Or psoriati c DMEC were subcultured in 12- well 
plates overnight to reach confluence. T he cells were ulltreated o r pre trea ted 
with 1 ng/ rnl o f T G F-/31 fo r 14 h and th en 10 units/ ml o f TNF-a wcre 
added to the well s. Afre r in cubatio ll for ano the r (, h, ce lls were washed three 
tim l!s wi th P13S and incubated at 37°C with 10 J.Lg/ml of monoclonal 
antibodies in PBS containing 2% fe tal bovine serum fo r 45 min. The ceUs 
were thell washed with PBS and were incubated with '10 J.Lg/ml o f 
flu orescein iso thiocyana te- conjugated goat anti - mo use Ig at 4°C fo r 45 
min . At the end of the incubation period. the ce lls were harves ted and 
analyzed by fl ow cyto l11 ctry (FACScan; Bedon Dickinson, San J ose, CAl . 
The fo llowing monoclonal antibodies were used : 84 H 10 (a nti-human 
IC AM-l). (,G l 0 (anti -hulllan VC AM- l). and H1 817 (anti-human E-sc lec-
tin). T he antibodies were used as purified ascites. 
Radio-Ligand Afftnity Binding Assay Normal and psoriatic DMEC 
were grown to confluence in 24- well plates and thell incubated fo r 24 h in 
DMEM suppkmented with 'I O'};, FBS. For cytokine stimulation, DMEC in 
24-well plates were pre treated w ith TNF-a fo r B h and with IL-4 fo r 24 h 
or as indica ted, Cells werc then rinsed and incubated at 37°C for 2 h in 
bindin~ medium (Du lbecco 's modified Eagle 's medium containin g 0.1 '% 
bovine se rum albumin and 25 mM H EPES buB'e r, p H 7.4) . Thl!reafter. ce lls 
were rinsed and incubated at 22°C fo r 2 h in binding medium containing l. 
to 300 picomolar 125 1-labeled T GF-,Bl (New England Nuclear, Boston. 
MA) . T o compare the afti ni ty o f TG F-,B binding and the number o f binding 
sites, in Some experiments. unstimulated or cy tokine-pretrea ted endotheli al 
cell s were al so incubated with 11S1_labeled T GF-,B fo r 2 h at 22°C. Binding 
datil were then eva luated by Scatchard analysis. NonspecifIC binding was 
determined in the prcsence of 50-fo ld excess unlabeled ligand . Each value 
in binding ex periments represents the mean of tripli cate samples. 
Cross-Linking Studies N orm ;]1 and psoria tic DMEC grown to conflu-
ence in 100-111111 di shes were washed with binding buffer (KlU-I buffer 
cotltaining O.StX. bovine s c rlllll alburnin) ;lnd incubated 011 icc in (he salllC 
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binding hufFer with 12s1-TG F_,B l in the presence and absence of exec 
unlabeled TGF-{31 for 4 h . At the end of the incubation period, the celli 
we re washed , and disuccinimidyl suberate (DSS; Pierce C hemical Co. 
R ockfo rd. IL), dissolved in DMSO, was "dded to a fmal concentration of 
200 /lM ;md incub:l tion was con tinued for 15 min at 4°C. The cross-linker 
was then quenched by adding glycine (1 0 mM fin al concentration. pH 7.j) 
and the cells were immediately lysed in dete rgent bufrer (10 mM Tris-Hel. 
pH 7.4, 125 mM NaC I, 1 mM ethylenediamine tctraacc tic acid , 1% Tri ton 
X-l00, and the foll owing protcase inhibitors: 10 J.Lg/m l p epstatin , 10 p,g/ ml 
Icupeptin. 10 /Lg/ rnl antipain , 100 J.Lg/ml benzamidine hydrochloride. 100 
J.Lg/ ml soybe;1I1 trypsi11 inhibitor, 50 ,..g/ml "protinin, and I 111M phenyl 
methyl sulfonate) and incuba ted fo r 60 mill at 4°C. The Iysates wcr. 
analyzed by sodium dodecyl sulf..1tc-po lyacrylamide gel electrophoresis 
(SDS-PAGE) using 10";', po lyacrylamide gels follo wed by autoradiography. 
Northern Blot Analysis T he TGF-,B receptor type I and type II III RNA 
levels in pso riatic and normal DMEC were evaluated by N orthern bIOI 
analysis. DMEC were grown to confluence in 'I DO-111m culture dishes , rinsed 
ill Dulbecco's modified Eagle's medium, and tot,i1I~A was isolated by acid 
guanidinjum thiocyana te-pheno l-chloro fo rnl extraction. Fo r Norrhern 
analysis, 20 J.Lg o f to tal RN A was size-fractionated by e lectrophoresis on 2% 
fo rmaldehyde gels and transferred to a nylon membrane (Gene Screen Plus) 
for hybridization under stringent conditiOns as described previously .. The 
cDNA probes used were: TG F-$ recepto r type I (3 .4 kb) [14] (a gift orDt. 
X iao-Fan Wang, Department o f Pharmacology, Dukl! Universi ty Medical 
Center. Durham , NC) and TGF-/3 recepto r type II (4 .5 kb) [11] (a gift of 
Dr. R o bert A. W einberg. Whitehead Ins titu te fo r Biomcdjcal Research. 
Cambridge , MA). The probes were labeled to a mean specifIC activity of 
5 X 108 cpml J.Lg using random o ligonucleo tide-primed synthesis kil 
(l3oeringc r-M annheim , Indianapoli s, IN) with la -32P] CTP (New England 
Nuclear, Boston, MA) . Fo llowing hybridization, filters were washed ill 0.5 
X sodium citrate/sodium chlo ride bufFer, 0.1 % SDS at 60°C for 20 min 
three times . dried , and exposed ·fo r auto radiography. Equal loading o(RNA 
WaS assessed by ,B-actin expression and e thidiuJl1 bromide staining of the gel. 
Autophosphorylation of TGF-,B Type U Receptor Normal and 
psoriati c DMEC were subcultured On 'IOIl-mm di shes to reach confluence. 
Cells were washed three times with phosphate-free mediulll (30 mM 
H E PES , pH 7.3 , 11 0 111M NaCI. 10 mM sucrose, S mM KC I, 2 mg/ ml of 
bovine serum albumin. i llIM C;,C I. 1 llIM MgC lz) and incubated in the 
sallle buB'er containing 0. 25 mC i/ ml .I 2P-o rthophosphate for 3 h at 37·C. 
5% CO2, The cells were then washed ofr free 32P-orthophosphate and 
harvested . T he cell pe llets were lysed at 4°C fo r 30 min in lysis buffer (1 0 
rnM Tris-HC1. '1% N onide t 1'-40. 50 mM sodium fluoride , 5 111M ethyl-
enediamine te traacctic acid , 5 111M sodium pyrophosphate, J 0 mM i odoacc~ 
ri c acid. 1 J.Lg/ ml leupeptin. 'J /lg/ml pepstatin). Afte r centrifugation for 30 
min at 13000 rpm the supernatant was preclcared two cycles with plain 
Sepharose 4B beads and protein-A 413 beads . T he Iysates were then 
incuba ted with 20 /-lg/ m\ ofa polyclonal rabbit anti-human TGF-{3 receptor 
/I 'lntibody overnight. The imll1line complexes were absorbed to protein A 
beads for'] h at 4°C and washed sequentiall y through a cushion o f IUPA 
buffer cOHtainjng 30% glycerol twice. IP-2 buffer twice, and PUS once. The 
immuno prccipitates were then solubili zed with SDS sample bulfer at 100·e 
for 5 min . Samples w ere electrophoresed using a 7.5% polyacrylamide gel 
fo llowed by auto radiograph y. 
RESULTS 
Effects of TGF-/31, TGF-{32, and TGF-{33 on DMEC Adhe-
siveness for PBMC Figurc ln sh ows that preinc ubation of 
n o rmal DMEC with TGF- J31 or TGF-132 for 8 h significantly 
d ecre ased binding of human PBMC. For both isoforms, maximal 
inhibition was observe d at con centrations of 0 .1 to 0.25 ng/ ml. 
Althoug h TGF-133 was able to bloc k PBMC adhesion, it was no t a 
potent as TGF-131 o r TGF-132 . In contrast, pre inc ubation of 
p soriatic DMEC with TGF-{31 , TGF- {32, or TGF-133 (Fig lb) for 
h had 110 effect all DMEC adhesive n ess for PBMC, e ven at TG F-p 
concentra t ions as high as 10 n g/ml. The results shown in Fig l b 
re present th e mean ± SD of obse rvations made on DMEC from 
seve n psoriati c patients. In othe r e x p e rime nts, prolonge d incuba-
ti o n o f psori a ti c DM EC with all three isoforl11s o f TGF-{3 for 48 It 
s til l did not show any sig nifI cant inhibitory e ffect on D ME 
adhes iv e n e ss (data Dot shown) . 
Effect of TGF-{3 Pretreatmcnt on TNF-a-Stitnulatcd E-
selectin Expression 011 Normal and Psoriatic DMEC Al 
shown in Table I, both normal and psoriatic endothelial cell 
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Figure 1. TGF-tJ decreases the adhesiveness of normal DMEC but 
not psoriatic DMEC for PBMC. Normal OMEC monolayers (n) or 
psoriatic DM.EC monolayer (b) were incubated with increasing concentra-
tions ofTGF-J3 I . TGF-J32. and TGF-J33 for 8 h. washed, and then tested for 
PBMC binding. The results arc expressed as mean :': SO of three experi-
ments for (n) and scven experiments using OMEC from sevcn psoriatic 
patients for (I,) . 
exhibited similar levels of baseline IC AM-1 expression. Stimulation 
of normal or psoriatic DMEC with TNF-a significantly augmented 
ICAM-1 and E-selectin expression on these cells. When normal 
DMEC were pretreated with T GF-J31 before stimulation with 
TNF-a, th e induction ofE-selectin, but not lCAM-1, was signifi-
cantly reduced (Table I) . In contrast, TGF-J31 failed to block the 
TNF- a - stimulated expression of E-selectin on psoriatic DMEC. In 
other scudies, TGF-J31 did not alter VCAM-1 expression on 
TNF- a -stimulated DMEC from normal skin (data not shown) . 
Affinity of Normal and Psoriatic DMEC for TGF-{31 The 
bi.nding curve of radioiodinated TGF-J31 ligand to normal DMEC 
(Fig 2a) and Scatchard analysis (Fig 211) showed that 1251_labeled 
TGF-J3 bo und to normal DMEC with both high and low affinities 
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Figure 2. TGF-tJ binds to normal DMEC with low and high affinity. 
Normal OMEC were cultured jn 24-w,,11 plates and specific 125I_TGF_J31 
binding [or ligand conccntrations ranging from 1 to 300 pM was dctermincd 
as describcd in MIIICI'inls nlld IHetlwd ... n) The binding curve of radio iodinated 
TGF-J31. IJ) Scatchard analysis of the specific radio-iodinated ligand. 
(K" of 24.8 pM and 235 pM, respectively). Similarly, psoriatic 
DMEC also express low - and hig h-affinity receptors. 
T he results of 125I_labeled TGF- J3 bindi.ng to normal and psori-
atic DMEC were shown in Fig 3a , w hich are representative of 
results obtained with DMEC from five normal subjects and seven 
psoriatic patients. Scatchard analysis shown in Fig 31J indicates 
there were no significant differences in both the aRinity and 
numbers of low-affinity receptors between no rmal and psoriatic 
DMEC. The number ofhigh-aftin.ity receptors on psoriatic DMEC 
(1594 receptors/cell), however, was markedly decreased compared 
w ith that of normal DMEC (4834 receptors/cell), altho ugh there 
was 110 signifi cant difference in the ligand binding affinity for each 
receptor (Kd = 11 .3 pM for psoriatic DMEC and 12.3 pM for 
110rmal DMEC) (Fig 3c) . 
In previous studies, we h ave reported that pretreatment of 
Table I. Differential Effect ofTGF-{31 on TNF-a-Stimulated E-Selectin and ICAM- l Expression in Normal and 
Psoriatic DMEC 
TGF-J31" TNF-ci Normal 
(ng/ml) (U/ml) DMEC 
0 0 5.85 :': 0.54' 
0 10 9.3 1 :': 1.1 2 
1.0 10 5.9 1 :': 0.62" 
" C ells were trc:Hcd w ith TGF-{31 for 20 It before assay. 
b TNF-a were :lclclcd to DMEC 6 It hefore assay. 
E-Sclectin 
Psoriatic 
DMEC 
5.49 :': 0.36 
10.75 :': 0.94 
11. 55 :': 0.82 
(" Mean Auorcsccll t:c expressed "s me'lll channel number of 5,OUO cell s. Ilcsults arc Il1C:\Il :!: SO of three experiments. 
41 p < 0.05 coru parcd with TNF-a treated alone. 
ICAM-l 
Normal Psoriatic 
DMEC DMEC 
10.75 ± 1.24 11 .86 :': 0.96 
21.90 :': 1.42 22.64 :': 1.36 
19.38 :': 2.06 2 1.1 3 :': 2.46 
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Fig ure 3. High-affinity TGF-13 receptors are decreased on DMEC 
from psoriatic plaques. Normal and psoriatic DMEC were cul tured in 
24-well plates 'Illd specific 125[-TGF-/31 binding was determined. n) 
Binding curve of radioiodinated TGF-/31 . b) Scatchard analysis of low-
affinity receptors . c) Scatchard analysis of high-affini ty receptors. Similar 
results were obtained with biopsies from five normal individuals and seven 
psoriatic patients. 
normal DMEC w ith 20 uni t/ml of IL-4 for 24 h signifi cantl y 
decreases DMEC response to the inhibitory effects ofTGF-{3. It was 
therefore of interest to investigate the effect o fIL- 4 pretreatme n t Oil 
125 I_TGF_{3 binding. Figure 4a sh ows the binding of 125I_labe led 
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F igure 4. The ligand binding affinity of TGF-13 receptors on nor-
mal DMEC are decreased b y IL-4. Normal DMEC were cultured in 
24-well plates and treated with 20 units/ ml of lL-4 for 24 h or medium 
alone, washed, and then assayed for specific binding of 125 [_ TGF-/3l. a) 
Binding curve of rad ioiodinated ligand. b) Scatchard anal ys is of low-affinity 
receptors. c) Scatchard ana lysis of high-affi nity receptors. R esults arc 
rcpresentative of three different experiments. 
TGF-{3 to contro l and IL-4 - t reated DMEC isolated from nonn al 
skin . Preincubation of normal DMEC w ith IL-4 for 24 h did not 
alter the aB-i ni ty or th e numbers of low- a flinity receptors (Fig 4b). 
Instead, IL-4 signifi cantl y (p < 0.01) decreased th e binding affinity 
VOL 106, NO.2 FEB R UARY 19% 
A B c D 
92.5 -
- Type II 
69 -
- Type J 
46 
Figure 5. Affinity labeling shows similar type I and type II TGF-{3 
receptor expression Oll norn,al and psoriatic DMEC. Normal (/nllcs A 
and C) and psoriatic ( /(/II("s Band 0) DMEC wcre cultured in 1 00-1ll11l di shes 
and affinity labeled by incubation with 125 1_ TGF-{31 in the absence (l nlle", A 
and B) or presence ( /nm·s C and 0) of excessive fl·cc TGF-f3·I. fo llowed by 
cross-linking with disuccinilllidyl subernte. Dl!tcrgent extracts from these 
cel.l s were analyzed by SDS-PAGE and autoradiography. T he location of 
type I and typ e JJ receptors \vcrc jndicated. 
of high-afr"inity TGF-J3 receptors (Kd = 7 pM for con tro l DMEC 
and 14.6 pM for rL-4-treated DMEC), altho ugh th e numbers of 
receptors (4196 receptors/cell of contro l DMEC, 4781 receptors/ 
ceU ofIL- 4 -treated DMEC) did n o e sig nifi c<1 ncl y diffe r (Fig 4c). In 
parallel experiments. in cuba tion of n o rmal DMEC w ith TN F-a for 
8 to 24 h , w hich did no t alte r eh e response to TGF-J3, had n o effect 
on eith er the numbers o r th e ligand binding affinity of TGF-J3 
receptors (data not sh own). 
Cross-Linking Studies T he express ion o f TGF- J3 receptors 
type I and II on DMEC fr'om no rmal ,lIld psol'iati c skin was 
inves tigated by c ross-lin king studi es. For this purpose, surface 
proteins o n DMEC were cross-linke d w ith 125 l-TGF_J31 , the cells 
lysed , and c ross-linked proteins ana lyzed by SDS- PAG E. As sh ow n 
in Fig 5 , afr"i ni ty-labcled pro duces o f the expec ted siz e for TG F-J3 
receptors type I and type 11 were detected on norma l aDd psoriatic 
DMEC. Moreover , pretreatment ofn o[mal DMEC with 20 unie/1ll1 
of lL-4 for 24 h did not change the expression pa ttem or in tensity 
of both type I aDd type II receptors (da ta n o t sh own). 
N orthern Blot Analysis ofTGF-J3 Receptor Type I and Type 
n W e next pe rfo rm ed Northern blot ana lys is to determine 
w bether difrerences in TGF-J3 receptor type I and type II expression 
can b e de tected at the steady-s taee mRNA level. T h e results in F ig 
6A showed simi la r leve ls of TGF- J3 receptol' type I I11RNA 
expression in no rmal (lall e A, den sitometer readin g : type 1IJ3- actin 
= 0.567) and psoriatic DMEC (Iallc B, type 1IJ3-actin = 0 .545). 
Figure 6B sh ows similar levels ofTGF- J3 receptor type II mRN A 
expressio n in no rmal (lall c A, type 11 / J3-actin = 0.402) and pSOI'iatic 
D MEC (lall e B, type 1l/(3- actin = 0.374) when the in tens ity of 
individua l bands w e re n orm alized against J3-actin expressio n . 
A utophosphorylation of TGF-J3 Receptor Type II It h as 
been demon strated recently that the type II receptor binds TGF-J3 
an d is a con stitutively active serine/threonin e k inase . III the last 
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Figure 6. Steady-state mRNA levels of type II and type I TGF-{3 
receptor arl! similar in normal and psoriatic DMEC. No,.,,,,,1 (Inlle A) 
and psoriatic (lnllt' B) DMEC wcre cul tured in 100-111111 dishes. Tota l cellular 
RNA was isola ted and analyzed by Northern hyblidization using the 
indicntl!d probl!s . T he amounts of mRNA wCre contro lled using J3-actin as 
:111 imerna l standard (densitometer read ing: Inlle A. trpc 1/ J3-acti ll = 0.567, 
type 11 /J3-actin = 0.402; Inll e B. rype II{3-actin = 0.545 . rype 1\ / J3-actin = 
0.374). Densitomctric ana lysis was pl!rforl11ed within the Linear range of the 
autoradiograph . 
series of experiments, the kinase actIvities of no rmal or pson atlc 
DMEC were investigated . W hen n ormal and pso riati c DMEC were 
assayed for TGF-J3 I'eceptor type II k in ase activities. aueophospho-
ryb ted TGF-J3 II recepeors w ere de tected in both no rmal and 
psoriatic DMEC (Fig 7) . Densitometric ana lysis revealed . however. 
that n orm al DMEC ex hibi ted twice am o un t of rad ioa ctivity of 32p 
co mpared w ith pso riatic DMEC, evell th ough identical Ilumber of 
cells w ere assayed for both normal and psoriatic DMEC. 
A B c D 
97 -
_ Type II 
66 -
Figure 7. Autophosphorylation of Type 1I TGF- {3 receptor is de-
creased in psoriatic DMEC. C ul tured nom1 ,,1 (/nlles .-1 and B) and 
psoriari c (/nllcs C and 0) DM EC wcre labeled with " "-orthophosphaTe. 
Detcrgl!nt extracts from these cells were il11l1l11110precipitatcd with a 
polyclol1 al rabbit "nti-hum an TGF-f3 receptor II antibody (lnll cs Band 0) Or 
normal rabbit 19 ( Inll ('s A and C). Immunoprecipita ted material was 
suhjcc tl!d to SDS-PAGE and an to radiography. 
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DISCUSSION 
T he presen t study shows th at TGF-J3 iso fo rms are capable of 
blocking lymphocyte adhesiveness of DMEC isola ted from norl11al 
slcin bu t not f1-om p sori atic plaques. TGF-J3 al so signifIcantly 
decreased the T NF-O'-stimulated E-selectin expression on norl11 al 
DMEC bu t not on psoriatic DMEC. T his is of particular interest 
because previous studies by o thers have sugges ted that E-selectin is 
an endothelial ligand recognized by cutaneo us lymphocyte an tigen 
[20,21] and other carbohydrates and may mediate slcin- specific 
lymphocyte adhesion to dermal vesse ls in inflamed skin. T he 
inability of TGF-(31 to in terfere with E-selectin induction in 
psoriatic DMEC may be one mechanism fo r the in tense mononu-
clea r cell infiltrates in psoriatic les ions. 
We have previously shown that th e emigration ofhuJ11an CD4 + 
T cells and the CD45RO + helper/inducer subset is promoted by 
selective adherence to psoriatic endothelium [3] . Although the 
exact pathogenesis of psoriasis remains unclear, these observations 
help explain the inflammatory infiltrate present in psoriatic p laques. 
More recently, we have shown that one possible mechanisnl at 
wotkin the influx of lymphocytes into psoriatic dermis is the 
inabitity of pSOliatic DMEC to respond to the negative effect of 
TGF-131 on DMEC adh esiveness for lymphocytes [8] . T hus, pso-
riatic DMEC escape . the downJegulatory effect of TGf-(3, and 
lymphocytes are unimpeded in the ir emigration into psoriatic 
pl aques. T he present findings begin to address the mechanjsm s 
in volved in psoriatic DMEC unrespon siveness to TGF-(3. Our 
results indicated the number of high-affl11ity TGF- j3 receptors on 
psoriatic DMEC was significantly decreased , aithough there was no 
alteration ill th e binding affinity of th e receptor. The decrease in 
TGF- {:l receptor expression iJ1 DMEC from psoriatic plaques was 
associated with a reduction in the autophosphorylation of the 
TGF-{3 receptor protein . Taken together, the present findings 
suggest that the abnorma li ty resides at the level ofTGF-J3 receptor 
expression and signal transduction . 
Recen t studies have demonstl'a ted the importance of TGF- J3 in 
modulating the lymphocyte binding properties of endoth elial cells 
(22). TGF-f3 blocks the abili ty of llnstil11uiated microvascular 
endothelial cells to bind monocytes, and T ceUs, and antagonizes 
the sti mulating activities of T NF-O' , IH-J - /" and granulocyte-
macrophage colony-stimulating facto r on DMEC (7,8). In terest-
ingly, TGF- J3 treatment of large vessel endothelial cells selectively 
blocks the TNF-induced E- selei::tin expression [23 ]. T he adminis-
tration ofTGF- {31 ill lI ilJo also prevents the infiltration of lympho-
cytes alid 1110nocytes in to lesions of coll agen-induced ar thri tis and 
expel'imental allergic encephalom yelitis [24). Furthermore, al-
though the initial development of TGF-{31 - deficient mice is nor-
mal , l11ultifocal inAal11l11atory cell infiltrates, comprised of lympho-
cytes and neutrophils, are observed 3 wk after birth . T lu s 
inAal11matiol1 is accompazued by tiss ue necrosis in organs such as 
hear t, lung, pancreas, saliv ary gland , and striated muscle leading to 
cachexia and death [25,26]. T hese findings in TGF-,Bl-deficien t 
mice provide the strongest support for th e hypothesis that TGF-f31 
. is important in the regu lation oflymphocyte traffic and implies tbat 
this function may not be compensated by other TGF-f3 isoform s. 
In this study, pretreatment of normal DMEC with lL-4 decreased 
the affinity o f TGF-,B receptors for its ligand, witho ut altering the 
llumber of binding sites. T lus find ing extends the previo us obser-
va tions that cytokines can alter the binding affinity of other cell 
surf.1ce receptors . For exampl e, TGF-{3 treatment has been shown 
to increase the binding affinity oflaminin receptors in human colon 
cancer ce lls [27]. TGF-,B can signi ficantly reduce the binding 
affinity of heparin-binding growth f.,ctor 1 receptor, however, w ith 
no concomitant change in receptor number [28]. Furthermore, 
treatment of human fibro blasts w ith .IFN-/, decreases th e binding 
affinity of the epidermal growth factor receptor [29]. 
In contrast to altera tion in ligand binding affi ni ty, there are 
several examples where cells have lost th eir abili ty to respond to 
TGF-,B through loss of receptors, most notably in neoplastic cell s. 
Thus, tumor cells often acquire resistance to the growth inhibitory 
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effects of TGF-(3 through defects in either ligand binding or 
downstream sig nal transductioll. A decrease in the lcvel ofTGF-~ 
type IT recepto r prote in has been demonstrated in retinoblastoma, 
gastric ca rcinoma, H odgkin lymphoma, aild cutaneous T cell 
lym phoma cells [16 ,1 7]. In the fEC-I S epithelial cell line, ~he 
decrease in TGF-f3 type II receptor expression is associated With 
over-expression of the H-ras oncogene and loss of TGF-{3-medl-
ated growth inhibiti on [30] . O ur resul ts ShOWUlg decreased number 
of hi gh-affinity TGF-,B receptors and type II receptor autopho -
phorylation in psoriatic DMEC suggest alteration in both TGF-/3 
receptor expression an d fun ction . Further studies, howeve~, are 
required to investigate whether additional defects in TGF-{3 SIgnal-
ing exist to account for the complete lack of response to dilferel1l 
TGF-(3 isoforms i.n psoriatic end o thelial cells. 
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